Núria Casals

This paper introduces a dual inhibitor targeting G9a and GSK-3β for Alzheimer's disease, showing improved memory and synaptic function in a mouse model.

The paper investigates how SSAO/VAP-1 affects BBB dysfunction and vascular BDNF release, leading to reduced synaptic markers in neurons in an Alzheimer's context.

This study shows that CPT1c in SF1 neurons is critical for satiety and fat metabolism during high-fat diet exposure, as its deficiency leads to impaired metabolic responses and increased obesity.

This study shows that beta-hydroxybutyrate (BHB) improves AMPA receptor levels and cognitive performance in mice exposed to a high-fat diet.